Form 4: Cardlytics CEO Amit Gupta Awarded 1.3 Million Equity Units in Compensation

Cardlytics, Inc. has granted its Chief Executive Officer and Director, Amit Gupta, a total of 1.3 million contingent equity units, comprising Restricted Stock Units and Performance Stock Units, as part of his compensation.

Summary

• Amit Gupta, the Chief Executive Officer and a Director of Cardlytics, Inc. (CDLX), was granted 1,000,000 Restricted Stock Units (RSUs) and 300,000 Performance Stock Units (PSUs) on June 23, 2025.
• Each RSU represents a contingent right to receive one share of Cardlytics' Common Stock.
• The RSU award will vest 50% on June 23, 2026, with the remaining 50% vesting in equal quarterly amounts over a one-year period through June 23, 2027, contingent on Mr. Gupta's continued employment.
• Each PSU represents a contingent right to receive one share of Cardlytics' Common Stock.
• The PSU award vests based on the achievement of specified price per share targets, also contingent on Mr. Gupta's continued employment.
• Following these transactions, Mr. Gupta beneficially owns 1,000,000 RSUs and 300,000 PSUs directly.

Sentiment

Score: 7

Explanation: The document reflects a positive event for the executive and generally for corporate governance, as it details a significant equity award designed to align management incentives with shareholder interests and promote long-term retention. While it implies potential future dilution, this is a standard aspect of equity compensation.

Positives

• The equity awards align the CEO's interests with shareholder value creation, as PSUs are tied to share price targets.
• The vesting schedule for RSUs and PSUs incentivizes long-term retention of a key executive.
• The grant of equity compensation is a common practice for executive remuneration, indicating standard corporate governance.

Negatives

• The awards represent potential future dilution for existing shareholders if all units vest and convert to common stock.
• The specific price targets for PSU vesting are not disclosed, limiting transparency on the performance hurdles.

Risks

• Vesting of both RSU and PSU awards is contingent on the Reporting Person's continued employment, posing a risk if employment ceases.
• PSU vesting is dependent on achieving specified price per share targets, which are subject to market conditions and company performance, and may not be met.

Future Outlook

The document outlines future vesting schedules for equity awards, indicating that 50% of RSUs will vest on June 23, 2026, with the remainder vesting quarterly through June 23, 2027. PSUs are set to vest upon achievement of unspecified future share price targets.

Industry Context

This Form 4 filing details an executive compensation event, which is a routine occurrence across all industries. The grant of performance-based equity (PSUs) is a common mechanism in the technology and financial services sectors, where Cardlytics operates, to align executive incentives with long-term shareholder value creation and company performance.

Comparison to Industry Standards

• The use of both time-based (RSUs) and performance-based (PSUs) equity awards is a standard practice in executive compensation packages across publicly traded companies, particularly in the technology and fintech sectors.
• The specific size of the award (1.3 million units) for a CEO of a company like Cardlytics would typically be benchmarked against peer companies of similar market capitalization, revenue, and industry, though specific comparable companies or projects are not detailed in this filing.

Stakeholder Impact

• Shareholders: Potential future dilution upon vesting and conversion of RSUs and PSUs into common stock. However, the PSU structure aims to benefit shareholders by tying vesting to share price appreciation.
• Employees: The award to the CEO may signal confidence in the company's future and its leadership, potentially boosting morale.
• Management: The awards provide significant financial incentives for the CEO to remain with the company and drive performance, particularly share price growth.

Next Steps

• The vesting of 50% of the RSU award is scheduled for June 23, 2026.
• The remaining 50% of the RSU award will vest in equal quarterly amounts through June 23, 2027.
• The PSU award will vest upon the achievement of specified price per share targets.

Key Dates

Recommendation

Keywords

Cardlytics, CDLX, Amit Gupta, Restricted Stock Units, Performance Stock Units, Equity Compensation, Executive Compensation, SEC Form 4, Insider Transaction, Stock Award, CEO